AstraZeneca’s (AZN) “Buy” Rating Reaffirmed at Shore Capital
Shore Capital restated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report published on Thursday, MarketBeat.com reports. A number of other equities analysts have also weighed in on AZN. JPMorgan Chase & Co. restated an “overweight” rating on shares of AstraZeneca in a research note on Monday, September […]
8 Nov 17:24 · The Markets Daily